HONG KONG SAR -
Media OutReach Newswire - 18 August 2025 - FWD Hong Kong ("FWD") has announced the launch of
"One&All Medical Insurance Plan" ("One&All"). True to its name,
One&All integrates Environmental, Social, and Governance
(ESG) principles into its design, offering flexible and affordable
medical protection for all. According to a recent survey by the Census
and Statistics Department¹, over half of Hong Kong's citizens do not
have personal medical insurance, highlighting a significant protection
gap in the market. Furthermore, the cost of self-financed treatments and
medicines may be underestimated if relying solely on public hospital
coverage. FWD introduces
"One&All" to address the need by bridging the gap. The
plan specifically targets Hong Kong public hospitals' self-financed
items and imaging tests referred to private medical institutions,
enabling more people to access the medical support they need.
FWD also announced its partnership with the Hong Kong Pharmaceutical
Care Foundation to offer a first-in-the-market² drug consultation and
medication management service for customers of
"One&All" and other designated medical insurance products, further enhancing their health management experience.
A customer-led solution to address pain points in public healthcare
Kelvin Yu, Chief Product Officer, FWD Hong Kong & Macau,
said: "Government statistics³ show that approximately 3% of patients
incur over HKD 10,000 in public hospital expenses, while the annual
out-of-pocket medication costs for cancer patients can reach up to HKD
400,000. The self-financed costs for drugs and medical items in the
public healthcare system create a significant financial burden for many
families. FWD has always been committed to a customer-first approach,
striving to bridge the public's health protection gap with innovative
products. The newly launched
"One&All Medical Insurance Plan" incorporates ESG principles to offer more accessible and affordable protection for our customers and the community.
"One&All" offers coverage segmented by hospital type,
addressing the pain points of those who lack adequate medical
protection, such as the inability to afford high-cost self-financed
items in public hospitals, or the risk of missing the crucial treatment
window due to long waiting times for imaging tests in the public system.
Optional benefit can also be applied for parents without any health
underwriting."
Kelvin added: "FWD is also actively expanding its medical
partnership network. We are delighted to collaborate with the Hong Kong
Pharmaceutical Care Foundation to provide customers of One&All and
other designated plans with a first-in-the-market², pharmacist-led drug
consultation and medication management service. This allows us to offer
comprehensive health support that goes beyond the insurance policy
itself."
Flexible protection across three benefit levels to suit different budgets and medical needs
The innovative
"One&All Medical Insurance Plan" is flexibly designed with
three benefit levels, allowing customers to choose their protection
based on geographical region, as well as public and private hospital
categories, catering to diverse budgets and cross-border medical needs:
- - Level Access: Features simplified underwriting⁴ with only
three simple health questions for enrolment, and daily premium being
less than HKD3
5. It is designed to provide basic protection for the
uninsured, covering self-financed items in Hong Kong public hospitals
and referrals to private facilities for imaging tests6 to
reduce waiting time. It also offers cash benefits for income loss due to
hospitalisation worldwide or day surgeries. The aggregate limit is up
to HKD 500,000 per disability7 per policy year.
- - Level Beyond: In addition to the benefits of Level Access,
this level extends coverage to treatment expenses in public and private
hospitals across Mainland China and Macau. Designed to meet the growing
demand for cross-border medical treatment, this plan offers Cross-border
Medical Services at the Greater Bay at a more affordable premium. The
aggregate limit is up to HKD 850,000 per disability7 per policy year.
- - Level Connect: Covers all benefits from Level Access and Level Beyond, and extends coverage to all public and private hospitals across Asia8, including Hong Kong and Mainland China. The aggregate limit is up to HKD 1,000,000 per disability7 per policy year. Uniquely, this plan allows customers to add an optional benefit9
for their parents. This feature is targeted at the problem of securing
coverage for parents, as they can be added to the plan with no health
underwriting or in-person signing required. Coverage similar to Level
Access can be enjoyed after the waiting period.
Expanding network of medical partners to help customers address medication concerns
As part of its ongoing network expansion, FWD collaborates with the Hong
Kong Pharmaceutical Care Foundation to offer first-in-the-market² drug
consultation and management services, providing eligible customers
10 with comprehensive health management that extends beyond medical insurance to address any medication-related concerns.
S C Chiang, Director, Hong Kong Pharmaceutical Care Foundation,
said: "With the rapid advancement of medical technology today, the
range of available medication is constantly increasing. When faced with
complex prescriptions, many people struggle to obtain adequate
consultation and guidance, which can lead to uncertainty and may even
impact treatment outcomes if medications are not used correctly. As a
non-profit charitable organisation dedicated to enhancing public
medication safety and promoting the professional services of
pharmacists, we deeply understand the importance of safe medication use.
Through this collaboration, we will provide FWD customers with
professional drug consultation and management services. This will offer
them clearer guidance on their medication and ensure they receive more
comprehensive and personalised health management support."
"
One&All" customers will have access to professional drug consultation and management services, including:
- - General drug inquiry service: A remote consultation service that
allows customers to easily resolve medication-related queries from the
comfort of their home
- - Professional pharmacist medication management service: One-on-one,
personalised medication consultation and management services from a
registered pharmacist
- - Dispensary discount
The "One&All Medical Insurance Plan" is underwritten by FWD Life
Insurance Company (Bermuda) Limited (incorporated in Bermuda with
limited liability) ("FWD"). The above content is for reference only and
does not constitute the full terms of coverage. Coverage is subject to
the terms and conditions of the policy. For complete terms and
conditions, benefits, exclusions, key product risks, and/or other
details of the plan, please refer to the FWD website and relevant
product brochure:
https://www.fwd.com.hk/en/medical-cover/one-n-all-medical-insurance-plan/.
-
Thematic Household Survey Report No. 78, Census and Statistics Department (https://www.censtatd.gov.hk/tc/press_release_detail.html'id=5515).
-
Per a comparison made by FWD with major insurance companies in Hong
Kong on 28 July 2025, FWD is the first insurer to collaborate with the
Hong Kong Pharmaceutical Care Foundation to offer this service.
-
Source: Secretary for Health, Professor Lo Chung-mau, in a media interview (https://news.hket.com/article/3781692).
-
Applicable to individuals with an age next birthday of 1 to 65. For
underwriting requirements, terms, and conditions, please refer to the
full underwriting questions.
-
According to standard premium (excluding any rider premiums, premium
discounts and levies), calculated based on an insured of age 28 (next
birthday) and an annual premium payment for One&All Medical
Insurance Plan (Level Access). The standard premium is non-guaranteed
and will be determined annually based on the insured's actual age at
renewal.
-
Tests covered include computed tomography ("CT" scan), magnetic
resonance imaging ("MRI" scan), positron emission tomography ("PET"
scan), PET-CT combined, PET-MRI combined, X-ray, mammogram, bone
densitometry, and ultrasound. The list of designated diagnostic imaging
tests, day surgeries, and healthcare service providers (hereinafter
referred to as the "List") will be published on the FWD website (www.fwd.com.hk/en/support/medical-support/).
FWD reserves the right to add, modify, or replace items on the List
from time to time without prior notice. Any changes will take effect on
the date specified in the updated List. FWD recommends that
policyholders and/or insured persons consult the latest List on the FWD
website before undergoing any designated diagnostic imaging tests or day
surgeries.
-
a. For each hospitalisation or day surgery due to the same illness,
the applicable benefit limit and/or per-illness annual policy year limit
will reset, provided that the hospitalisation or day surgery does not
occur within 90 consecutive days from the last discharge date or day
surgery date related to the same illness.
b. If the insured person is hospitalised or undergoes day surgery
for more than one illness during the same confinement or day surgery
session, all illnesses involved will be subject to a single applicable
benefit limit and/or per-illness annual policy year limit.
-
Asia includes Afghanistan, Australia, Bangladesh, Bhutan, Brunei,
Cambodia, Mainland China, Hong Kong, India, Indonesia, Japan,
Kazakhstan, Kyrgyzstan, Laos, Macau, Malaysia, Maldives, Mongolia,
Myanmar, Nepal, New Zealand, North Korea, Pakistan, Philippines,
Singapore, South Korea, Sri Lanka, Taiwan, Tajikistan, Thailand,
Timor-Leste, Turkmenistan, Uzbekistan, and Vietnam.
-
The "Family Booster for Parent Option" is an optional benefit
available when the policyholder selects Level Connect of the plan. Any
benefit amount paid under the Family Booster for Parent Option will not
count toward any applicable benefit limits under this plan and will not
affect the insured person's eligibility for benefits and/or no-claim
premium discounts under this plan.
-
"Eligible customers" refer to insured persons under designated
medical insurance plans. "Designated medical insurance plans" refer to
the One&All Medical Insurance Plan. Designated insurance products
are subject to availability, and FWD reserves the sole and absolute
discretion to amend the definition of designated insurance products from
time to time without prior notice. For detailed terms and conditions of
the product policy, please refer to the product brochure and policy
document.
Photo Caption: (from left to right): Kelvin Yu, Chief Product Officer, FWD Hong Kong & Macau, and S C Chiang, Director, Hong Kong Pharmaceutical Care Foundation, jointly announce the first-in-the-market² drug consultation and medication management service for customers of “One&All” and other designated medical products.